Just in time for 420, we have what may be the most important step yet towards an international standard for quality and purity in cannabis. On Monday, the United States Pharmacopeial Convention (USP) published a paper titled “Cannabis Inflorescence for Medical Purposes: USP Considerations for Quality Attributes” in the Journal of Natural Products and according to the paper, “The principles outlined in this review should be able to be used as the basis of public quality specification for cannabis inflorescence (flowers)…”
Our President, Josh Wurzer, has been serving for several years as an independent expert on the USP’s Cannabis Expert Panel and is one of the co-authors of the paper. SC Labs was proud to be able to contribute data as well as our test methodology to the effort.
Standards published by the USP for drugs, dietary supplements, or food, when published in either the USP-NF or Food Chemicals Codex, are recognized by US federal law and, in some cases, internationally. This paper is the first step towards similar recognition of a unified set of cannabis standards by the federal government.
The principles outlined in this review should be able to be used as the basis of public quality specification for cannabis inflorescence (flowers)